Cinamon G, Grabovsky V, Winter E, Franitza S, Feigelson S, Shamri R, Dwir O, Alon R
Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.
J Leukoc Biol. 2001 Jun;69(6):860-6.
The recruitment of circulating leukocytes at vascular sites in target tissue has been linked to activation of Gi-protein signaling in leukocytes by endothelial chemokines. The mechanisms by which apical and subendothelial chemokines regulate leukocyte adhesion to and migration across endothelial barriers have been elusive. We recently found that endothelial chemokines not only stimulate integrin-mediated arrest on vascular endothelial ligands but also trigger earlier very late antigen (VLA)-4 integrin-mediated capture (tethering) of lymphocytes to vascular cell adhesion molecule 1 (VCAM-1)-bearing surfaces by extremely rapid modulation of integrin clustering at adhesive contact zones. This rapid modulation of integrin avidity requires chemokine immobilization in juxtaposition with the VLA-4 ligand VCAM-1. We also observed that endothelial-bound chemokines promote massive lymphocyte transendothelial migration (TEM). It is interesting that chemokine-promoted lymphocyte TEM requires continuous exposure of lymphocytes but not of the endothelial barrier to fluid shear. It is noteworthy that lymphocyte stimulation by soluble chemokines did not promote lymphocyte TEM. Our results suggest new roles for apical endothelial chemokines both in triggering lymphocyte capture to the endothelial surface and in driving post-arrest events that promote lymphocyte transmigration across endothelial barriers under shear flow.
循环白细胞在靶组织血管部位的募集与内皮趋化因子激活白细胞中的Gi蛋白信号传导有关。顶端和内皮下趋化因子调节白细胞黏附于内皮屏障并穿越内皮屏障的机制一直难以捉摸。我们最近发现,内皮趋化因子不仅刺激整合素介导的在血管内皮配体上的停滞,还通过在黏附接触区极快速地调节整合素聚集,触发早期极迟抗原(VLA)-4整合素介导的淋巴细胞与携带血管细胞黏附分子1(VCAM-1)的表面的捕获(系留)。整合素亲和力的这种快速调节需要趋化因子与VLA-4配体VCAM-1并列固定。我们还观察到内皮结合的趋化因子促进大量淋巴细胞跨内皮迁移(TEM)。有趣的是,趋化因子促进的淋巴细胞TEM需要淋巴细胞持续暴露于流体剪切力,但不需要内皮屏障持续暴露于流体剪切力。值得注意的是,可溶性趋化因子刺激淋巴细胞并不能促进淋巴细胞TEM。我们的结果表明,顶端内皮趋化因子在触发淋巴细胞捕获到内皮表面以及驱动促进淋巴细胞在剪切流作用下跨内皮屏障迁移的捕获后事件中具有新作用。